Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A: Post Hoc: Analysis of the CREDENCE Trial : Clinical Journal of the American Society of Nephrology

Journal Logo

Original Article: Diabetes and the Kidney

Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR

A Post Hoc Analysis of the CREDENCE Trial

van der Hoek, Sjoukje1; Jongs, Niels1; Oshima, Megumi2,3; Neuen, Brendon L.3; Stevens, Jasper1; Perkovic, Vlado4; Levin, Adeera5; Mahaffey, Kenneth W.6; Pollock, Carol7; Greene, Tom8; Wheeler, David C.9; Jardine, Meg J.10; Heerspink, Hiddo J.L.1,3

Author Information
Clinical Journal of the American Society of Nephrology ():10.2215/CJN.0000000000000161, March 31, 2023. | DOI: 10.2215/CJN.0000000000000161
  • Buy
  • SDC
  • PAP
  • Infographic

Abstract

Copyright © 2023 by the American Society of Nephrology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid